Cargando…

BCL2 genotypes and prostate cancer survival

PURPOSE: The antiapoptotic B‑cell lymphoma 2 (BCL2) gene is a key player in cancer development and progression. A functional single-nucleotide polymorphism (c.-938C>A, rs2279115) in the inhibitory P2 BCL2 gene promoter has been associated with clinical outcomes in various types of cancer. Aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renner, Wilfried, Langsenlehner, Uwe, Krenn-Pilko, Sabine, Eder, Petra, Langsenlehner, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438415/ https://www.ncbi.nlm.nih.gov/pubmed/28396899 http://dx.doi.org/10.1007/s00066-017-1126-9

Ejemplares similares

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014)

A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival
por: Hofmann, Guenter, et al.
Publicado: (2009)

Haptoglobin polymorphism and prostate cancer mortality
por: Kaiser, Melanie, et al.
Publicado: (2020)

The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer
por: Knittelfelder, Olivia, et al.
Publicado: (2020)

The Erythropoetin rs1617640 Gene Polymorphism Associates with Hemoglobin Levels, Hematocrit and Red Blood Cell Count in Patients with Peripheral Arterial Disease
por: Renner, Wilfried, et al.
Publicado: (2020)

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
por: Partl, Richard, et al.
Publicado: (2020)

The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy
por: Delago, Daniela, et al.
Publicado: (2020)

Impact of UGT2B7 (His268Tyr )polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer
por: Parmar, Sumit, et al.
Publicado: (2011)

The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy
por: Knittelfelder, Olivia, et al.
Publicado: (2020)

TRPC4α and TRPC4β Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation
por: Kirschmer, Nadine, et al.
Publicado: (2016)

Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer
por: Partl, Richard, et al.
Publicado: (2020)

The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients
por: Yazdani-Biuki, Babak, et al.
Publicado: (2006)

The Pre-Treatment Platelet-to-Lymphocyte Ratio as a Prognostic Factor for Loco-Regional Control in Locally Advanced Rectal Cancer
por: Partl, Richard, et al.
Publicado: (2023)

Can Pre-Treatment Inflammatory Parameters Predict the Probability of Sphincter-Preserving Surgery in Patients with Locally Advanced Low-Lying Rectal Cancer?
por: Partl, Richard, et al.
Publicado: (2021)

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy
por: Chen, Shukun, et al.
Publicado: (2019)

Catch and Release: rare cell analysis from a functionalised medical wire
por: Chen, Shukun, et al.
Publicado: (2017)

BCL-2 is dispensable for thrombopoiesis and platelet survival
por: Debrincat, M A, et al.
Publicado: (2015)

Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2021)

Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
por: Cao, Hongwen, et al.
Publicado: (2019)

Expression of the Bcl-2 Protein BAD Promotes Prostate Cancer Growth
por: Smith, Adrienne J., et al.
Publicado: (2009)

Low spinophilin expression enhances aggressive biological behavior of breast cancer
por: Schwarzenbacher, Daniela, et al.
Publicado: (2015)

Praf2 Is a Novel Bcl-xL/Bcl-2 Interacting Protein with the Ability to Modulate Survival of Cancer Cells
por: Vento, Maria Teresa, et al.
Publicado: (2010)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X(L) cell survival genes
por: Maciel-Silva, Paula, et al.
Publicado: (2018)

Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound
por: Pilko, Gasper, et al.
Publicado: (2011)

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
por: Searle, Claire J, et al.
Publicado: (2012)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping
por: Moazami-Goudarzi, Mozhagan, et al.
Publicado: (2016)

Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival
por: Braun, Frédérique, et al.
Publicado: (2013)

Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
por: Fairlie, Walter Douglas, et al.
Publicado: (2021)

Hedgehog Signaling Regulates the Survival of Gastric Cancer Cells by Regulating the Expression of Bcl-2
por: Han, Myoung-Eun, et al.
Publicado: (2009)

BCL2 enhances survival of porcine pluripotent stem cells through promoting FGFR2
por: Zhu, Zhenshuo, et al.
Publicado: (2020)

Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide
por: Pilling, Amanda B., et al.
Publicado: (2019)

Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer
por: Lee, Erinna F., et al.
Publicado: (2021)

Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells
por: Priault, Muriel, et al.
Publicado: (2010)

Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.
por: Chaudhary, K S, et al.
Publicado: (1999)

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for (68)Ga-PET imaging of prostate cancer
por: Schäfer, Martin, et al.
Publicado: (2012)

Bcl-2 family member Bcl-G is not a proapoptotic protein
por: Giam, M, et al.
Publicado: (2012)

Merkel Cell Carcinoma Dependence on Bcl-2 Family Members for Survival
por: Verhaegen, Monique E., et al.
Publicado: (2014)

Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
por: Kulsoom, Bibi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cv0etbv5iba718lu1pu2b4nvrn